RISS 학술연구정보서비스

검색
다국어 입력

http://chineseinput.net/에서 pinyin(병음)방식으로 중국어를 변환할 수 있습니다.

변환된 중국어를 복사하여 사용하시면 됩니다.

예시)
  • 中文 을 입력하시려면 zhongwen을 입력하시고 space를누르시면됩니다.
  • 北京 을 입력하시려면 beijing을 입력하시고 space를 누르시면 됩니다.
닫기
    인기검색어 순위 펼치기

    RISS 인기검색어

      KCI등재 SCIE SCOPUS

      Effects of Mizoribine on MHC-Restricted Exogenous Antigen Presentation in Dendritic Cells

      한글로보기

      https://www.riss.kr/link?id=A104666889

      • 0

        상세조회
      • 0

        다운로드
      서지정보 열기
      • 내보내기
      • 내책장담기
      • 공유하기
      • 오류접수

      부가정보

      다국어 초록 (Multilingual Abstract)

      Mizoribine (MZR) has been shown to possess immunosuppressive activity that selectively inhibits the proliferation of lymphocytes by interfering with inosine monophosphate dehydrogenase.
      The efficacy of MZR is not only in patients who have had renal transplantation, but also in patients with rheumatoid arthritis (RA), lupus nephritis, and primary nephritic syndrome.
      Because the exact mechanism of its immunosuppressive action is not clear, the object of this study was to examine the ability of MZR to regulate the antigen presenting cells (APCs), dendritic cells (DCs). In this work, we tested whether MZR (1~10 μg/mL) could inhibit the crosspresentation of DCs. DC2.4 cells (H-2Kb) or bone marrow-derived DCs (BM-DCs) generated from BM cells of C57BL/6 mouse (H-2Kb) were cultured in the presence of MZR with OVAmicrospheres, and the amount of OVA peptide-class I MHC complexes was measured by a T cell hybridoma, B3Z, that recognizes OVA (257-264 : SIINFEKL)-H-2Kb complex and expresses- galactosidase. MZR profoundly inhibited the expression of SIINFEKL-H-2Kb complexes.
      This inhibitory activity of MZR appeared to affect the phagocytic activity of DCs. MZR also decreased IL-2 production when we examined the effects of MZR on CD4+ T cells. These results provide an understanding of the mechanism of immunosuppressive activity of MZR on the inhibition of MHC-restricted antigen presentation and phagocytic activity in relation to their actions on APCs.
      번역하기

      Mizoribine (MZR) has been shown to possess immunosuppressive activity that selectively inhibits the proliferation of lymphocytes by interfering with inosine monophosphate dehydrogenase. The efficacy of MZR is not only in patients who have had renal tr...

      Mizoribine (MZR) has been shown to possess immunosuppressive activity that selectively inhibits the proliferation of lymphocytes by interfering with inosine monophosphate dehydrogenase.
      The efficacy of MZR is not only in patients who have had renal transplantation, but also in patients with rheumatoid arthritis (RA), lupus nephritis, and primary nephritic syndrome.
      Because the exact mechanism of its immunosuppressive action is not clear, the object of this study was to examine the ability of MZR to regulate the antigen presenting cells (APCs), dendritic cells (DCs). In this work, we tested whether MZR (1~10 μg/mL) could inhibit the crosspresentation of DCs. DC2.4 cells (H-2Kb) or bone marrow-derived DCs (BM-DCs) generated from BM cells of C57BL/6 mouse (H-2Kb) were cultured in the presence of MZR with OVAmicrospheres, and the amount of OVA peptide-class I MHC complexes was measured by a T cell hybridoma, B3Z, that recognizes OVA (257-264 : SIINFEKL)-H-2Kb complex and expresses- galactosidase. MZR profoundly inhibited the expression of SIINFEKL-H-2Kb complexes.
      This inhibitory activity of MZR appeared to affect the phagocytic activity of DCs. MZR also decreased IL-2 production when we examined the effects of MZR on CD4+ T cells. These results provide an understanding of the mechanism of immunosuppressive activity of MZR on the inhibition of MHC-restricted antigen presentation and phagocytic activity in relation to their actions on APCs.

      더보기

      참고문헌 (Reference)

      1 "Vesicles bearing MHC class II molecules mediate transfer of antigen from antigen presenting cells to CD4 + T cells" 29 : 1363-1373, 1999

      2 "TCR Mediated internalization of peptide MHC complexes acquired y T cells" 286 : 952-954, 1999

      3 "T cells can use either T cell receptor or CD28 receptors to absorb and internalize cell surface molecules derived from antigen presenting cells" 191 : 1137-1148, 2000

      4 "Studies on immunosuppression with low-dosecyclosporine combined with mizoribine in experimental andclinical cadaveric renal allotransplantation" kuma : 1598-1600, 1989

      5 "Studies on antinephriticeffect of mizoribine effect on the nephrotictype of anti-GBM nephritis in rats" 541-548, 1983

      6 "Role of bone marrow-derived cells inpresenting MHC class I-restricted tumor antigens" 961-965, 1994

      7 "Presentation of exogenous protein antigens on major histocompatibility complex class I molecules by dendritic cells pathway of presentation and regulation by cytokines" 90 : 1594-1599, 1997

      8 "Pharmacokinetic study of mizoribine in an adolescent with lupus nephritis" 46 : 597-600, 2004

      9 "Modification ofcrescentic Masugi nephritis in the rabbit by Bredinin" a newimmunosuppressant Incl 103-119, 1983

      10 "Mizoribine as an effective combined maintenance therapy with prednisolone in child onset systemic lupus erythematosus" 44 : 199-204, 2002

      1 "Vesicles bearing MHC class II molecules mediate transfer of antigen from antigen presenting cells to CD4 + T cells" 29 : 1363-1373, 1999

      2 "TCR Mediated internalization of peptide MHC complexes acquired y T cells" 286 : 952-954, 1999

      3 "T cells can use either T cell receptor or CD28 receptors to absorb and internalize cell surface molecules derived from antigen presenting cells" 191 : 1137-1148, 2000

      4 "Studies on immunosuppression with low-dosecyclosporine combined with mizoribine in experimental andclinical cadaveric renal allotransplantation" kuma : 1598-1600, 1989

      5 "Studies on antinephriticeffect of mizoribine effect on the nephrotictype of anti-GBM nephritis in rats" 541-548, 1983

      6 "Role of bone marrow-derived cells inpresenting MHC class I-restricted tumor antigens" 961-965, 1994

      7 "Presentation of exogenous protein antigens on major histocompatibility complex class I molecules by dendritic cells pathway of presentation and regulation by cytokines" 90 : 1594-1599, 1997

      8 "Pharmacokinetic study of mizoribine in an adolescent with lupus nephritis" 46 : 597-600, 2004

      9 "Modification ofcrescentic Masugi nephritis in the rabbit by Bredinin" a newimmunosuppressant Incl 103-119, 1983

      10 "Mizoribine as an effective combined maintenance therapy with prednisolone in child onset systemic lupus erythematosus" 44 : 199-204, 2002

      11 "Mizoribine and mycophenolate mofetil" 6 : 575-597, 1999

      12 "Mechanism of action of the immunosup-presive drug mizoribine" Sinclair 1991

      13 "Inhibition of expression of Cyclin A in human B cells by an immunosuppressant Mizoribine" 155 : 5175-5183, 1995

      14 "Inhibition of cyclin A gene expression in human B cells by an immunosuppressant mizoribine" 120 : 448-453, 2000

      15 "Dendritic cells resurrect antigens from dead cells" 22 : 141-148, 2001

      16 "Cyclosporin A and tacrolimus but not rapamycin inhibit MHC restricted antigen" 105 : 3951-3955, 2005

      17 "Cloned dendritic cells can present exogenous antigens on both MHC class I and class II molecules" 158 : 2723-2730, 1997

      18 "Class II MHC peptide complexes are released from APC and are acquired by T cell responders during Effects of Mizoribine on MHC Restricted Exogenous Antigen Presentation in Dendritic Cells 1153 specific antigen recognition" 163 : 5201-5210, 1999

      19 "Cell surfaceappearance of unexpected host MHC determinants on thy-mocytes from radiation bone marrow chimeras" immu (immu): 1327-1335, 1981

      20 "CTLs rapidly capture membrane fragments from target cells in a TCR signaling dependent manner" 166 : 3645-3649, 2001

      21 "Antigen presentation by T cells T cell receptor ligation promotes antigen acquisition from professional antigen presenting cells" 27 : 3198-3205, 1997

      22 "Antigen capture processing and presentation by dendritic cells recent cell biological studies" 60 : 562-567, 1999

      23 "Acquisition of CD80 by T cells" 166 : 2505-2513, 2001

      더보기

      동일학술지(권/호) 다른 논문

      동일학술지 더보기

      더보기

      분석정보

      View

      상세정보조회

      0

      Usage

      원문다운로드

      0

      대출신청

      0

      복사신청

      0

      EDDS신청

      0

      동일 주제 내 활용도 TOP

      더보기

      주제

      연도별 연구동향

      연도별 활용동향

      연관논문

      연구자 네트워크맵

      공동연구자 (7)

      유사연구자 (20) 활용도상위20명

      인용정보 인용지수 설명보기

      학술지 이력

      학술지 이력
      연월일 이력구분 이력상세 등재구분
      2023 평가예정 해외DB학술지평가 신청대상 (해외등재 학술지 평가)
      2020-01-01 평가 등재학술지 유지 (해외등재 학술지 평가) KCI등재
      2010-01-01 평가 등재학술지 유지 (등재유지) KCI등재
      2008-01-01 평가 등재학술지 유지 (등재유지) KCI등재
      2006-01-01 평가 등재학술지 유지 (등재유지) KCI등재
      2004-01-01 평가 등재학술지 유지 (등재유지) KCI등재
      2001-01-01 평가 등재학술지 선정 (등재후보2차) KCI등재
      1998-07-01 평가 등재후보학술지 선정 (신규평가) KCI등재후보
      더보기

      학술지 인용정보

      학술지 인용정보
      기준연도 WOS-KCI 통합IF(2년) KCIF(2년) KCIF(3년)
      2016 1.96 0.2 1.44
      KCIF(4년) KCIF(5년) 중심성지수(3년) 즉시성지수
      1.07 0.87 0.439 0.05
      더보기

      이 자료와 함께 이용한 RISS 자료

      나만을 위한 추천자료

      해외이동버튼